U.S. markets open in 2 hours 30 minutes

Cisco Systems, Inc. (CSCO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
45.92+1.05 (+2.34%)
At close: 4:00PM EST

45.89 -0.03 (-0.07%)
Pre-Market: 7:00AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close44.87
Bid45.81 x 1800
Ask45.96 x 900
Day's Range45.22 - 46.22
52 Week Range32.40 - 49.34
Avg. Volume19,585,603
Market Cap193.865B
Beta (5Y Monthly)0.91
PE Ratio (TTM)19.21
Earnings DateN/A
Forward Dividend & Yield1.48 (3.30%)
Ex-Dividend DateApr 05, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
15% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • IBM Expands Hybrid Cloud Service, Targeting Banks, Health Care

    IBM Expands Hybrid Cloud Service, Targeting Banks, Health Care

    (Bloomberg) -- International Business Machines Corp. has publicly released its hybrid cloud service, furthering its plan to pivot the business toward the fast-growing market for storing large amounts of data on the internet.The expanded offering, called IBM Cloud Satellite, allows customers to control how they store their information, with some of it held internally in what’s known as private cloud, and other data stored in public clouds such as Amazon.com Inc’s AWS, or Microsoft Corp’s Azure. As a latecomer to cloud services, IBM is targeting highly-regulated industries such as banking and health care, which have been slow to adopt internet-based storage solutions due to security concerns and scale.For these industries, the integration of public and private clouds has been “too complex, too expensive, and a huge amount of risk,” said Howard Boville, head of hybrid cloud at IBM. To accommodate such clients, Cloud Satellite is designed to streamline cybersecurity, and make regulatory compliance “invisible,” Boville said.IBM sees the evolution as a crucial step in Chief Executive Officer Arvind Krishna’s vision to transform the century-old company into a modern enterprise focused on hybrid cloud and artificial intelligence. IBM has collaborated with 65 companies, including Dell, Intel Corp., and Cisco Systems Inc., to help customers run workloads and to provide input on Cloud Satellite’s development.Lumen Technologies, previously known as CenturyLink, will be a Cloud Satellite partner, and deploy the service at 180,000 enterprise locations. The ability to offer the Cloud Satellite service to companies where the data now lives, will help offer reassurance to businesses whose data is highly sensitive and who have been hesitant to move it to a public storage site, according to IBM.“Only 20% of enterprise data is in the cloud today, we have an opportunity to help migrate 80% of mission-critical workloads to the cloud,” IBM said in a statement Monday.Since becoming CEO last spring, Krishna has moved quickly to implement the transformation plan for IBM. During an investor call in January, Krishna said that he was confident the company’s focus on those areas can help it achieve revenue growth in 2021, reversing a ten-quarter trend of no growth or declines in sales.Krishna, who previously headed IBM’s cloud division, was the driving force behind the company’s $34 billion purchase of open source software provider Red Hat in 2018, the first step toward transitioning IBM into what it sees as a $1 trillion hybrid-cloud market. The company is also expected to complete a spin off of its managed infrastructure services unit into a separate publicly traded company this year.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Better Buy: Arista Networks vs. Juniper Networks
    Motley Fool

    Better Buy: Arista Networks vs. Juniper Networks

    At the time, I concluded that Arista's higher gross margins and forward-thinking approach to replacing physical routers with cloud-based software made it the better networking play. Arista's stock subsequently rallied nearly 40% as Juniper's stock advanced about 20%. Arista only sells networking switches and software-based networking services.

  • Bloomberg

    ‘Death Squad’ That Tossed 2,000 Patents Challenged at High Court

    (Bloomberg) -- The U.S. Supreme Court will consider whether to declare unconstitutional a system that technology companies, including Apple Inc. and Google Inc., have used to invalidate hundreds of patents and head off litigation.In an argument at the intersection of intellectual property and the separation of powers, the justices on Monday will consider a challenge to a congressionally-created board that critics have dubbed a “death squad” because of its tendency to toss out patents.The Patent Trial and Appeal Board has invalidated more than 2,000 patents since it began work in 2012. Apple says it alone has used the board to successfully attack almost 200 patents, many held by entities interested only in filing lawsuits and extracting royalties. Congress set up the board, known as PTAB, in 2011 as a faster and cheaper alternative to litigation.But some smaller inventors see a chance to undercut the board, saying it’s become an anticompetitive tool for large companies.The case “has the potential to shut down the PTAB, if only for a moment until Congress can do something to get it back on course,” said Jim Carmichael, a former PTAB judge and now managing director of Carmichael IP. “For many inventors and patent owners, that’s a very exciting prospect.”At issue is whether more than 250 PTAB judges are serving in violation of the Constitution. The federal appeals court that handles most patent disputes said the judges have important enough powers that they need to be appointed directly by the president.Should the Supreme Court agree, it could go as far as barring the board from continuing to review and invalidate patents. The justices could also issue a more limited ruling that would strip the judges of their job protections but leave the board’s powers intact. Either way, a decision against the board could mean that hundreds of cases would have to be reconsidered.Constitutional FightThe U.S. Court of Appeals for the Federal Circuit said the judges are “principal officers,” a constitutional category that requires presidential appointment and Senate confirmation. The court said it reached that conclusion in part because patent judges’ decisions, typically issued by three-person panels, aren’t subject to review by a presidentially appointed official at the agency.The Justice Department is urging the Supreme Court to leave the system in place, saying patent judges are “inferior officers,” who the Constitution says don’t have be presidential appointees. In a brief filed before leaving office, President Donald Trump’s administration said the Patent & Trademark Office director and the Commerce secretary together have broad control over the work of the judges. Among other tools, the patent office director can decide which judges sit on a review panel.The Supreme Court said in a 1997 case involving Coast Guard judges that inferior officers are people “whose work is directed and supervised at some level by others who were appointed by presidential nomination with the advice and consent of the Senate.”The case before the justices involves an Arthrex Inc. surgical device patent invalidated by PTAB after a challenge by Smith & Nephew Plc. The court has deferred action in dozens of other cases likely to be affected by its ruling.Technology CompaniesApple, the single biggest user of the review boards, filed a brief backing Arthrex. The iPhone maker said it relies “on Congress’s promise of a fair and efficient forum to challenge what often prove to be woefully weak patents that should not have issued in the first instance.”Other companies backing PTAB include Intel Corp. and an alliance whose members include Alphabet Inc.’s Google, Cisco Systems Inc., Microsoft Corp., Oracle Corp. and Samsung Electronics Co.A group describing itself as “39 aggrieved inventors” said intellectual property rights are “under attack by large corporations that are motivated to devalue patents and quell competition.”“There is no place for overlooking constitutional violations and contrived, convoluted administrative shortcuts when the future of small businesses and their owners’ livelihoods hang in the balance,” the group said.The drug industry is largely staying out of the fight, though a trade group for the generic-drug industry urged the court to preserve the PTAB.So many patents have been invalidated that it’s been called a “death squad,” a term coined by Randall Rader, the former chief judge of the Federal Circuit, which oversees all patent disputes in the country. The patent office has since altered its rules, giving patent owners a better shot at surviving the challenges.PTAB already survived one challenge at the Supreme Court. In 2018, justices found the panel wasn’t unconstitutionally wielding powers that belong to the courts.The court is scheduled to rule by late June. The lead case is U.S. v. Arthrex, 19-1434.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.